CellVoyant

We see the future in cells

  • Biotech
Therapeutics

Member

Active

Status

2021

Founded

Development stage

  • Old Market
    Incubator residents

CellVoyant is accelerating the development of novel stem cell-based therapies for chronic diseases. Its technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, enable advanced cell analytics and ultimately unlock the controllable manufacturing of any cell and tissue in the body at scale. Built on foundational research at the University of Bristol, CellVoyant works at the intersection of cell biology, computing, engineering and machine learning to carry out its mission.

Founding team

Key contacts